clinicaloptions.com
Jun 20, 2025, 08:05
Justin Taylor: Roche, AbbVie Announce Trial of Venclexta in Patients with Myelodysplastic Syndromes Falls Short
Justin Taylor, Assistant Professor at the UM Sylvester Comprehensive Cancer Center, shared a post on X:
“Wow, big news today! Was not expecting this and leaves a big unmet need still for MDS.
Roche, AbbVie say trial of Venclexta in patients with myelodysplastic syndromes falls short.”
More posts featuring Justin Taylor on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 1, 2025, 19:24
Aug 1, 2025, 19:14
Aug 1, 2025, 18:32